No More ‘Annual’ Pap Smears For Many Woman, According to New Guidelines
November 20, 2009
(ChattahBox) — Only days after a federal panel caused controversy after recommending changing the starting age for breast cancer screening for many women from age 50 rather than 40, another organization, the American College of Obstetricians and Gynecologists, has done the same for a screening credited with drastically reducing the rates of cervical cancer in the U.S. Read more
Good News Guys! Beer is Good for Your Heart
November 19, 2009
(ChattahBox)— According to a Spanish study, daily moderate consumption of alcohol reduces the risk of coronary heart disease in men, by at least 35 percent and downing from three to 11 shots of liquor per day reduced the risk even further, by a whopping 50 percent. Of course excessive drinking can cause other problems, such as liver disease, dementia and stroke, but coronary heart disease would not be a concern. Read more
Task Force Suggests Putting Off Regular Mammograms Until Age 50
November 17, 2009
(ChattahBox) — A controversial recommendation regarding mammograms was revealed earlier today by a key government panel reversing the standard held for 20 years, telling that women to get a mammogram when they turn 40. Now a government recommendation is telling women they can wait until 50, a stunning reversal and a break with the American Cancer Society’s long-standing position. Read more
New Drug May Unlock Cure For Rare And Deadly Lung Cancer
November 11, 2009
U.K (ChattahBox) - A new drug has raised hopes for a cure to a highly deadly strain of lung cancer that kills all but 3% of those that develop it.
American Medical Association Endorses Marijuana Research and Repeal of ‘don’t ask,don’t tell’
November 11, 2009
(ChattahBox) — The American Medical Association House of Delegates has called for a review of the U.S. ban on prescribing marijuana for medical use. Meeting in Houston, the group declined to endorse state-based medical marijuana programs but urged the federal government to loosen the classification of marijuana as a Schedule I drug. Other drugs classified as Schedule I, the most restrictive of the federal government’s five schedules, include heroin and LSD, and is the only classification of controlled substances that may not be prescribed by a physician. The AMA’s goal in changing its policy is to clear the way for clinical research, development of marijuana-based medicines, and creation of alternate ways to deliver the drug.
Read more
Woman Opens Up About The Horrors Of Her ‘Vagina Falling Out’
November 9, 2009
Washington (ChattahBox) - A 39-year-old school psychologist on MomLogic.com has released a story about her struggled with, as she put it, her ‘vagina falling out’.
New Cure Could Offer Hope For Rare Disease, As Baby Saved
November 5, 2009
Australia (ChattahBox) - A baby in Melbourne suffering from a disease that dissolves the brain has been saved from death. after an experimental drug was used successfully.
First H1N1 case in a cat confirmed
November 5, 2009
(ChattahBox) — A cat in Iowa has tested positive for the H1N1 virus, “marking the first time a cat has been diagnosed with this strain of influenza,” according to state officials. Officials said the 13-year-old cat started sneezing and quit eating after two people in its home contracted suspected cases of the flu. The cat was taken to Iowa State University’s veterinary college, where tests confirmed this week that it had the new flu virus. All members of the household, including the cat, recovered. H1N1 has now been documented in cats, humans, pigs, birds, and ferrets.
Read more
Hunger in America: Half of Our Kids on Food Stamps
November 3, 2009
(ChattahBox)—A new study finds that nearly half of all American children will need to use the federal food stamp program to eat at some point in their childhood, with the number much higher for African American children, at a startling 90 percent. And the current recession with persistently high unemployment rates, will cause the numbers of children on food stamps to rise even higher, say researchers. Read more
First Potential Lupus Treatment Achieves Positive Results in Clinical Trial
November 2, 2009
(ChattahBox) — Human Genome Sciences (HGS) and GlaxoSmithKline (GSK) today announced positive results from BLISS-76, the second of two large-scale phase III clinical trials of BENLYSTA(TM) (belimumab) for treating systemic lupus. A full presentation of results from BLISS-52 was recently shared at the 73rd Annual Scientific meeting of the American College of Rheumatology. Both trials succeeded in meeting their primary endpoints, which should make BENLYSTA eligible for approval by the U.S. Food and Drug Administration (FDA).
Both trials demonstrate that treatment with BENLYSTA plus standard of care was superior to that of placebo (inactive agent) plus standard of care. BENLYSTA significantly reduced disease activity. Still, the drug did not perform as well in the second trial as in the first. That might temper what was expected to be a big rise in Human Genome’s stock on Monday. If approved by the FDA, BENLYSTA would be the first drug ever developed and approved specifically for the treatment of lupus. Read more